Proteomic analysis revealed the important role of vimentin in human cervical carcinoma HeLa cells treated with gambogic acid

Molecular and Cellular Proteomics

Volumn 15, Issue 1, 2016, Pages 26-44

  Yue, Qingxi ^a,b,c   Feng, Lixing ^a   Cao, Biyin ^d   Liu, Miao ^a   Zhang, Dongmei ^a   Wu, Wanying ^a   Jiang, Baohong ^a   Yang, Min ^a   Liu, Xuan ^a   Guo, Dean ^a,c  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE INHIBITOR; GAMBOGIC ACID; GLUTAMIC ACID; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE P38; SERINE; VIMENTIN; PROTEOME; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MCF 7 CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR XENOGRAFT; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; ANIMAL; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CONFOCAL MICROSCOPY; DRUG EFFECTS; DRUG SCREENING; G2 PHASE CELL CYCLE CHECKPOINT; GENETICS; MCF-7 CELL LINE; METABOLISM; NUDE MOUSE; PROCEDURES; RNA INTERFERENCE; TIME FACTOR; TUMOR CELL LINE; TUMOR VOLUME; TWO DIMENSIONAL GEL ELECTROPHORESIS; UTERINE CERVICAL NEOPLASMS;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; HELA CELLS; HUMANS; MCF-7 CELLS; MICE, NUDE; MICROSCOPY, CONFOCAL; PROTEOME; PROTEOMICS; RNA INTERFERENCE; TANDEM MASS SPECTROMETRY; TIME FACTORS; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS; VIMENTIN; XANTHONES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84955449294     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M115.053272     Document Type: Article

References (47)

1. Ren, Y., Yuan, C., Chai, H. B., Ding, Y., Li, X. C., Ferreira, D., and Kinghorn, A. D. (2011) Absolute configuration of (-)-gambogic acid, an antitumor agent. J. Nat. Products 74, 460-463
2. Chen, J., Gu, H. Y., Lu, N., Yang, Y., Liu, W., Qi, Q., Rong, J. J., Wang, X. T., You, Q. D., and Guo, Q. L. (2008) Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells. Life Sci. 83, 103-109
3. Xu, Y., Ouyang, J., Zhang, Q. G., Zhou, M., Li, J., Chen, M. M., and Xu, Y. Y. (2012) [Gambogic acid induces apoptosis of Jurkat cell through the MAPK signal pathway]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20, 587-591
4. Zhu, X., Zhang, H., Lin, Y., Chen, P., Min, J., Wang, Z., Xiao, W., and Chen, B. (2009) Mechanisms of gambogic acid-induced apoptosis in non-small cell lung cancer cells in relation to transferrin receptors. J. Chemother. 21, 666-672
5. Zaks-Makhina, E., Li, H., Grishin, A., Salvador-Recatala, V., and Levitan, E. S. (2009) Specific and slow inhibition of the kir2.1 K+ channel by gambogic acid. J. Biol. Chem. 284, 15432-15438
6. Rahman, M. A., Kim, N. H., and Huh, S. O. (2013) Cytotoxic effect of gambogic acid on SH-SY5Y neuroblastoma cells is mediated by intrinsic caspase-dependent signaling pathway. Mol. Cell. Biochem. 377, 187-196
7. Xu, X., Liu, Y., Wang, L., He, J., Zhang, H., Chen, X., Li, Y., Yang, J., and Tao, J. (2009) Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells. Int. J. Dermatol. 48, 186-192
8. Shu, W., Chen, Y., Li, R., Wu, Q., Cui, G., Ke, W., and Chen, Z. (2008) Involvement of regulations of nucleophosmin and nucleoporins in gambogic acid-induced apoptosis in Jurkat cells. Basic Clin. Pharmacol. Toxicol. 103, 530-537
9. Pandey, M. K., Sung, B., Ahn, K. S., Kunnumakkara, A. B., Chaturvedi, M. M., and Aggarwal, B. B. (2007) Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. Blood 110, 3517-3525
10. Boran, A. D., and Iyengar, R. (2010) Systems pharmacology. Mount Sinai J. Med. 77, 333-344
11. Yue, Q. X., Xie, F. B., Guan, S. H., Ma, C., Yang, M., Jiang, B. H., Liu, X., and Guo, D. A. (2008) Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenes. Cancer Sci. 99, 1461-1470
12. Feng, L., Zhang, D., Fan, C., Ma, C., Yang, W., Meng, Y., Wu, W., Guan, S., Jiang, B., Yang, M., Liu, X., and Guo, D. (2013) ER stress-mediated apoptosis induced by celastrol in cancer cells and important role of glycogen synthase kinase-3beta in the signal network. Cell Death Dis. 4, e715
13. Yoshikawa, T., Ogata, N., Izuta, H., Shimazawa, M., Hara, H., and Takahashi, K. (2011) Increased expression of tight junctions in ARPE-19 cells under endoplasmic reticulum stress. Curr. Eye Res. 36, 1153-1163
14. Yue, Q. X., Song, X. Y., Ma, C., Feng, L. X., Guan, S. H., Wu, W. Y., Yang, M., Jiang, B. H., Liu, X., Cui, Y. J., and Guo, D. A. (2010) Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells. Phytomedicine 17, 606-613
15. Ma, C., Yue, Q. X., Guan, S. H., Wu, W. Y., Yang, M., Jiang, B. H., Liu, X., and Guo, D. A. (2009) Proteomic analysis of possible target-related proteins of cyclophosphamide in mice thymus. Food Chem. Toxicol. 47, 1841-1847
16. Yue, Q. X., Cao, Z. W., Guan, S. H., Liu, X. H., Tao, L., Wu, W. Y., Li, Y. X., Yang, P. Y., Liu, X., and Guo, D. A. (2008) Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-auto- mated estimation of the possible drug target network. Mol. Cell. Proteomics 7, 949-961
17. Zeng, Y. Y., Chen, H. J., Shiau, K. J., Hung, S. U., Wang, Y. S., and Wu, C. C. (2012) Efficient enrichment of phosphopeptides by magnetic TiO(2)-coated carbon-encapsulated iron nanoparticles. Proteomics 12, 380-390
18. Nagaraj, S. H., Harsha, H. C., Reverter, A., Colgrave, M. L., Sharma, R., Andronicos, N., Hunt, P., Menzies, M., Lees, M. S., Sekhar, N. R., Pandey, A., and Ingham, A. (2012) Proteomic analysis of the abomasal mucosal response following infection by the nematode, Haemonchus contortus, in genetically resistant and susceptible sheep. J. Proteomics 75, 2141-2152
19. Lam, M. P., Scruggs, S. B., Kim, T. Y., Zong, C., Lau, E., Wang, D., Ryan, C. M., Faull, K. F., and Ping, P. (2012) An MRM-based workflow for quantifying cardiac mitochondrial protein phosphorylation in murine and human tissue. J. Proteomics 75, 4602-4609
20. Xu, P., Li, J., Shi, L., Selke, M., Chen, B., and Wang, X. (2013) Synergetic effect of functional cadmium-tellurium quantum dots conjugated with gambogic acid for HepG2 cell-labeling and proliferation inhibition. Int. J. Nanomed. 8, 3729-3736
21. Zhao, W., Zhou, S. F., Zhang, Z. P., Xu, G. P., Li, X. B., and Yan, J. L. (2011) Gambogic acid inhibits the growth of osteosarcoma cells in vitro by inducing apoptosis and cell cycle arrest. Oncology Reports 25, 1289-1295
22. Yu, J., Guo, Q. L., You, Q. D., Zhao, L., Gu, H. Y., Yang, Y., Zhang, H. W., Tan, Z., and Wang, X. (2007) Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis 28, 632-638
23. Dave, J. M., and Bayless, K. J. (2014) Vimentin as an integral regulator of cell adhesion and endothelial sprouting. Microcirculation 21, 333-344
24. Pallari, H. M., and Eriksson, J. E. (2006) Intermediate filaments as signaling platforms. Science's STKE 366, pe53
25. Satelli, A., and Li, S. (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell. Mol. Life Sci. 68, 3033-3046
26. Shirahata, A., Sakuraba, K., Kitamura, Y., Yokomizo, K., Gotou, T., Saitou, M., Kigawa, G., Nemoto, H., Sanada, Y., and Hibi, K. (2012) Detection of vimentin methylation in the serum of patients with gastric cancer. Anticancer Res. 32, 791-794
27. Song, B. P., Jain, S., Lin, S. Y., Chen, Q., Block, T. M., Song, W., Brenner, D. E., and Su, Y. H. (2012) Detection of hypermethylated vimentin in urine of patients with colorectal cancer. J. Mol. Diagn. 14, 112-119
28. Tozser, J., Bagossi, P., Boross, P., Louis, J. M., Majerova, E., Oroszlan, S., and Copeland, T. D. (1999) Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates. Eur. J. Biochem. 265, 423-429
29. Byun, Y., Chen, F., Chang, R., Trivedi, M., Green, K. J., and Cryns, V. L. (2001) Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ. 8, 443-450
30. Nakajima, E., Hammond, K. B., Rosales, J. L., Shearer, T. R., and Azuma, M. (2011) Calpain, not caspase, is the causative protease for hypoxic damage in cultured monkey retinal cells. Invest. Ophthalmol. Visual Sci. 52, 7059-7067
31. Nakamura, N., Tsuru, A., Hirayoshi, K., and Nagata, K. (1992) Purification and characterization of a vimentin-specific protease in mouse myeloid leukemia cells. Regulation during differentiation and identity with cathepsin G. Eur. J. Biochem. 205, 947-954
32. Sihag, R. K., Inagaki, M., Yamaguchi, T., Shea, T. B., and Pant, H. C. (2007) Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments. Exp. Cell Res. 313, 2098-2109
33. Ando, S., Tanabe, K., Gonda, Y., Sato, C., and Inagaki, M. (1989) Domainand sequence-specific phosphorylation of vimentin induces disassembly of the filament structure. Biochemistry 28, 2974-2979
34. Eriksson, J. E., He, T., Trejo-Skalli, A. V., Harmala-Brasken, A. S., Hellman, J., Chou, Y. H., and Goldman, R. D. (2004) Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments. J. Cell Sci. 117, 919-932
35. Aziz, A., Hess, J. F., Budamagunta, M. S., Voss, J. C., and Fitzgerald, P. G. (2010) Site-directed spin labeling and electron paramagnetic resonance determination of vimentin head domain structure. J. Biol. Chem. 285, 15278-15285
36. Lahat, G., Zhu, Q. S., Huang, K. L., Wang, S., Bolshakov, S., Liu, J., Torres, K., Langley, R. R., Lazar, A. J., Hung, M. C., and Lev, D. (2010) Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies. PloS One 5, e10105
37. Guo, K., Kang, N. X., Li, Y., Sun, L., Gan, L., Cui, F. J., Gao, M. D., and Liu, K. Y. (2009) Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis. BMC Cancer 9, 100
38. Acunzo, J., Katsogiannou, M., and Rocchi, P. (2012) Small heat shock proteins HSP27 (HspB1), alphaB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death. Int. J. Biochem. Cell Biol. 44, 1622-1631
39. Clements, R. T., Feng, J., Cordeiro, B., Bianchi, C., and Sellke, F. W. (2011) p38 MAPK-dependent small HSP27 and alphaB-crystallin phosphorylation in regulation of myocardial function following cardioplegic arrest. Am. J. Physiol. 300, H1669-H1677
40. Jia, Y., Wu, S. L., Isenberg, J. S., Dai, S., Sipes, J. M., Field, L., Zeng, B., Bandle, R. W., Ridnour, L. A., Wink, D. A., Ramchandran, R., Karger, B. L., and Roberts, D. D. (2010) Thiolutin inhibits endothelial cell adhesion by perturbing Hsp27 interactions with components of the actin and intermediate filament cytoskeleton. Cell Stress Chaperones 15, 165-181
41. Lee, J. S., Zhang, M. H., Yun, E. K., Geum, D., Kim, K., Kim, T. H., Lim, Y. S., and Seo, J. S. (2005) Heat shock protein 27 interacts with vimentin and prevents insolubilization of vimentin subunits induced by cadmium. Exp. Mol. Med. 37, 427-435
42. Zheng, C., Lin, Z., Zhao, Z. J., Yang, Y., Niu, H., and Shen, X. (2006) MAPK-activated protein kinase-2 (MK2)-mediated formation and phosphorylation- regulated dissociation of the signal complex consisting of p38, MK2, Akt, and Hsp27. J. Biol. Chem. 281, 37215-37226
43. Nomura, H., Uzawa, K., Ishigami, T., Kouzu, Y., Koike, H., Ogawara, K., Siiba, M., Bukawa, H., Yokoe, H., Kubosawa, H., and Tanzawa, H. (2008) Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: An immunohistochemical study of premalignant and malignant lesions of the oral cavity. BMC Cancer 8, 39
44. Honore, B., and Vorum, H. (2000) The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells. FEBS Letts. 466, 11-18
45. Zhou, Z. T., and Wang, J. W. (2007) Phase I human tolerability trail of Gambogic acid. Chin. New Drugs 16, 435-437
46. Chi, Y., Zhan, X. K., Yu, H., Xie, G. R., Wang, Z. Z., Xiao, W., Wang, Y. G., Xiong, F. X., Hu, J. F., Yang, L., Cui, C. X., and Wang, J. W. (2013) An open-labeled, randomized, multicenter phase IIa study of gambogic acid injection for advanced malignant tumors. Chin. Med. J. 126, 1642-1646
47. Li, X., Liu, S., Huang, H., Liu, N., Zhao, C., Liao, S., Yang, C., Liu, Y., Zhao, C., Li, S., Lu, X., Liu, C., Guan, L., Zhao, K., Shi, X., Song, W., Zhou, P., Dong, X., Guo, H., Wen, G., Zhang, C., Jiang, L., Ma, N., Li, B., Wang, S., Tan, H., Wang, X., Dou, Q. P., and Liu, J. (2013) Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo. Cell Reports 3, 211-222